2nd Quarter - Report
EISAI INC. for EISAI INC.
Firm
Client
Income
—
Expenses
$610,000
Expense method
A: Lobbying Disclosure Act definitions
What was lobbied
5 issue areas, each in the filer's own words, with who lobbied on it and where.
Financial Institutions/Investments/Securities FIN
Student Loan Auction Rate Securities
| Lobbyist | Covered position, as disclosed |
|---|---|
| PETER NORMAN | — |
| KATIE OPPENHEIM | Legislative Assistant, Sen. Mike Crapo |
Taxation/Internal Revenue Code TAX
Branded prescription pharmaceutical fee under the Accountable Care Act
| Lobbyist | Covered position, as disclosed |
|---|---|
| PETER NORMAN | — |
| KATIE OPPENHEIM | Legislative Assistant, Sen. Mike Crapo |
Medicare/Medicaid MMM
Medicare coverage and reimbursement issues (cuts to Medicare Part B and coverage of obesity medications)
| Lobbyist | Covered position, as disclosed |
|---|---|
| PETER NORMAN | — |
| KATIE OPPENHEIM | Legislative Assistant, Sen. Mike Crapo |
Education EDU
Student Loan Auction Rate Securities
| Lobbyist | Covered position, as disclosed |
|---|---|
| PETER NORMAN | — |
| KATIE OPPENHEIM | Legislative Assistant, Senator Mike Crapo |
Pharmacy PHA
Food and Drug Administration-Drug Enforcement Agency coordination and scheduling issues drug importation Prescription Drug User Fee Act reauthorization (HOPE Act, supply chain integrity)
| Lobbyist | Covered position, as disclosed |
|---|---|
| PETER NORMAN | — |
| KATIE OPPENHEIM | Legislative Assistant, Sen. Mike Crapo |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.